Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study. (Q51324403)
Jump to navigation
Jump to search
scientific article published on 29 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study. |
scientific article published on 29 April 2014 |
Statements
Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study (English)
Yutaka Seino
Atsushi Fukatsu
Michito Ubukata
Soichi Sakai
Yoshishige Samukawa